CoChat

Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA

Open access
Yoshioka, Naohisa, Dowdy, Steven F. · 2017 · PLOS ONE

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

We previously devised a polycistronic, synthetic self-replicating RNA (srRNA) to generate human induced Pluripotent Stem Cells (iPSCs) that simultaneously expresses four reprogramming factors (4F). However, while the best 4F srRNA efficiently generated iPSCs from young fibroblasts, it was inefficient on adult human fibroblasts (>50 years). To increase the iPSC generation efficiency, we included additional reprogramming factors. We found that a single transfection of a five factor (5F) srRNA, containing OCT4, KLF4, SOX2, GLIS1 and c-MYC, robustly generated iPSCs from adult human fibroblasts aged 54 to 77 and from a 24 year old cardiomyopathy patient donor. Interestingly, 5F-srRNA induced LIN28A, which was one of the original reprogramming factors. 5F-srRNA also accelerated the generation of iPSCs by seven days compared to 4F-srRNAs. Further improvements include phosphatase treatment to remove 5' phosphate and use of Lipofectamine MessengerMAX that increased transfection efficiency to ~90%. Together, these improvements enabled us to efficiently generate iPSCs from human fibroblasts using 5F-srRNA while eliminating both puromycin selection and feeder cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0182018

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Construction and expression of srRNA. A: Scheme of Self-Replicating srRNA constructs. B: Expression of reprogramming factors in OKS-iM 4F-srRNA, OKS-iG 4F-srRNA, OKS-iGM 5F-srRNA, and OKS-iGML 6F-srRNA on day 2 (left) and day 10 (right). BJ cells were co-transfected with srRNAs plus B18R mRNA (1:1 srRNA:B18R mRNA), selected with puromycin and cultured in Advanced DMEM/10% FBS for 10 days. C: qRT-PCR analysis of LIN28A and NANOG from 4F-srRNA and 5F-srRNA transfected BJ cells normalized to GAPDH. Cells were selected with puromycin after the transfection, and cultured in Advanced DMEM/10% FBS (Ad) or ES medium. Cells were collected on day 2, 4, 6, 8 and 10 for 5F-srRNA, and day 10 for 4F-srRNA (OKS-iM and OKS-iG). D: Immunoblot analysis of LIN28A and NANOG in 5F-srRNA transfected BJ cells on day 6 and 10. iPSC: iPSC clone generated with 5F-srRNA from BJ cells.
Fig 1 Construction and expression of srRNA. A: Scheme of Self-Replicating srRNA constructs. B: Expression of reprogramming factors in OKS-iM 4F-srRNA, OKS-iG 4F-srRNA, OKS-iGM 5F-srRNA, and OKS-iGML 6F-srRNA on day 2 (left) and day 10 (right). BJ cells were co-transfected with srRNAs plus B18R mRNA (1:1 srRNA:B18R mRNA), selected with puromycin and cultured in Advanced DMEM/10% FBS for 10 days. C: qRT-PCR analysis of LIN28A and NANOG from 4F-srRNA and 5F-srRNA transfected BJ cells normalized to GAPDH. Cells were selected with puromycin after the transfection, and cultured in Advanced DMEM/10% FBS (Ad) or ES medium. Cells were collected on day 2, 4, 6, 8 and 10 for 5F-srRNA, and day 10 for 4F-srRNA (OKS-iM and OKS-iG). D: Immunoblot analysis of LIN28A and NANOG in 5F-srRNA transfected BJ cells on day 6 and 10. iPSC: iPSC clone generated with 5F-srRNA from BJ cells.CC BY · PubMed Central
Fig 2 Comparison of iPSC generation with 4F-srRNA, 5F-srRNA and 6F-srRNA. A: iPSC generation in BJ cells. Cell images on day 7, 10, and 21. ES culture medium was used starting on day 7. Scale bar, 100 μm. B: iPSC generation in BJ cells. iPSC colonies were stained with Alkaline Phosphatase (AP) on day 21 and 28. TRA-1-60 and SSEA4 staining was performed after AP staining. On day 10, a starting well was passaged to 3 wells for OKS-iM, 2 wells for OKS-iG and 5F-srRNA. C: Day 21 iPSC colonies from adult human fibroblasts, FB#31, FB#32 and FB#33, from 5F-srRNA were stained with AP and TRA-1-60. FB#31, 55 year old healthy male donor, FB#32: 54 year old healthy female donor, FB#33: 24 year old cardiomyopathy male donor. D: Day 28 iPSC colonies from adult human fibroblasts, FB#31, FB#32 and FB#33, were stained with AP and TRA-1-60. A starting well was passaged to 3 wells for OKS-iM, 1 well for OKS-iG and 2 wells for 5F-srRNA. E: iPSC generation in feeder-free conditions. iPSC colonies were generated on Laminin- 521 or Matrigel. BJ cells were co-transfected with 5F-srRNA plus B18R mRNA (1:1 ratio), and selected with puromycin, then passaged onto Laminin-521 or Matrigel. iPSC colonies were stained with AP and TRA-1-60 on day 21. Scale bar, 100 μm. F: iPSC generation without puromycin selection. BJ cells were co-transfected with 5F-srRNA plus B18R mRNA (1:1 ratio), then on day 5, one well was passaged into 6 wells. AP staining and TRA-1-60, TRA-1-80, or SSEA4 staining were performed on day 24. The numbers of AP positive colonies per starting well were counted and are summarized in Tables 1 and 2.
Fig 2 Comparison of iPSC generation with 4F-srRNA, 5F-srRNA and 6F-srRNA. A: iPSC generation in BJ cells. Cell images on day 7, 10, and 21. ES culture medium was used starting on day 7. Scale bar, 100 μm. B: iPSC generation in BJ cells. iPSC colonies were stained with Alkaline Phosphatase (AP) on day 21 and 28. TRA-1-60 and SSEA4 staining was performed after AP staining. On day 10, a starting well was passaged to 3 wells for OKS-iM, 2 wells for OKS-iG and 5F-srRNA. C: Day 21 iPSC colonies from adult human fibroblasts, FB#31, FB#32 and FB#33, from 5F-srRNA were stained with AP and TRA-1-60. FB#31, 55 year old healthy male donor, FB#32: 54 year old healthy female donor, FB#33: 24 year old cardiomyopathy male donor. D: Day 28 iPSC colonies from adult human fibroblasts, FB#31, FB#32 and FB#33, were stained with AP and TRA-1-60. A starting well was passaged to 3 wells for OKS-iM, 1 well for OKS-iG and 2 wells for 5F-srRNA. E: iPSC generation in feeder-free conditions. iPSC colonies were generated on Laminin- 521 or Matrigel. BJ cells were co-transfected with 5F-srRNA plus B18R mRNA (1:1 ratio), and selected with puromycin, then passaged onto Laminin-521 or Matrigel. iPSC colonies were stained with AP and TRA-1-60 on day 21. Scale bar, 100 μm. F: iPSC generation without puromycin selection. BJ cells were co-transfected with 5F-srRNA plus B18R mRNA (1:1 ratio), then on day 5, one well was passaged into 6 wells. AP staining and TRA-1-60, TRA-1-80, or SSEA4 staining were performed on day 24. The numbers of AP positive colonies per starting well were counted and are summarized in Tables 1 and 2.CC BY · PubMed Central
Fig 3 Characterization of iPSC clones from 5F-srRNA. A: qRT-PCR analysis of ES cells markers on 5F-srRNA iPSC clones. Expression of ES marker genes were normalized to GAPDH. B: Immunofluorescence analysis of ES markers in 5F-srRNA iPSC clones from BJ, FB#31, FB#32 and FB#33. Scale bar, 100 mm. C: Teratoma formation of 5F-srRNA iPSC clones. iPSC clones were injected intramuscular or subcutaneous into NRG mice. Teratomas were allowed to form for 4–6 months after injection. Four of five BJ-5F-iPSC clones (#1, 3, 4, 5), three of three FB#31-5F-iPSC clones (#1, 2, 3), and one of two FB#33-5F-iPSC clones (#3) generated teratomas. Cartilage (a, b, c), muscle (d, e, f), neural tissue (g), pigmented epithelium (h), squamous epithelium (i), intestinal epithelium (j, f), and respiratory epithelium (k). Scale bar, 50 μm. D: qRT-PCR for srRNA (nsP1 region) was performed on FB#31, FB#32, and FB #33 -5F-srRNA iPSC clones. Total RNA was isolated from passage 5 (P5) cells. * = no detected amplification.
Fig 3 Characterization of iPSC clones from 5F-srRNA. A: qRT-PCR analysis of ES cells markers on 5F-srRNA iPSC clones. Expression of ES marker genes were normalized to GAPDH. B: Immunofluorescence analysis of ES markers in 5F-srRNA iPSC clones from BJ, FB#31, FB#32 and FB#33. Scale bar, 100 mm. C: Teratoma formation of 5F-srRNA iPSC clones. iPSC clones were injected intramuscular or subcutaneous into NRG mice. Teratomas were allowed to form for 4–6 months after injection. Four of five BJ-5F-iPSC clones (#1, 3, 4, 5), three of three FB#31-5F-iPSC clones (#1, 2, 3), and one of two FB#33-5F-iPSC clones (#3) generated teratomas. Cartilage (a, b, c), muscle (d, e, f), neural tissue (g), pigmented epithelium (h), squamous epithelium (i), intestinal epithelium (j, f), and respiratory epithelium (k). Scale bar, 50 μm. D: qRT-PCR for srRNA (nsP1 region) was performed on FB#31, FB#32, and FB #33 -5F-srRNA iPSC clones. Total RNA was isolated from passage 5 (P5) cells. * = no detected amplification.CC BY · PubMed Central
Fig 4 5F-srRNA iPSC generation with messengerMax transfection. A: Comparison of Lipofectamine 2000 and MessengerMax transfection efficiency. GFP srRNA was co-transfected with B18R mRNA (1: 1 ratio) into BJ cells and GFP expression was measured by flow cytometry on day 2. B: 5F-srRNA was co-transfected with B18R mRNA (1:1 ratio) into BJ cells, and selected for puromycin for 4 days (Day 5). Scale bar, 200 μm. C: Comparison of iPSC generation with Lipofectamine-2000 and MessengerMax transfection. iPSC colonies were generated, and stained with AP, TRA-1-60, SSEA4 and SSEA1, as indicated.
Fig 4 5F-srRNA iPSC generation with messengerMax transfection. A: Comparison of Lipofectamine 2000 and MessengerMax transfection efficiency. GFP srRNA was co-transfected with B18R mRNA (1: 1 ratio) into BJ cells and GFP expression was measured by flow cytometry on day 2. B: 5F-srRNA was co-transfected with B18R mRNA (1:1 ratio) into BJ cells, and selected for puromycin for 4 days (Day 5). Scale bar, 200 μm. C: Comparison of iPSC generation with Lipofectamine-2000 and MessengerMax transfection. iPSC colonies were generated, and stained with AP, TRA-1-60, SSEA4 and SSEA1, as indicated.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

Metadata

Authors
Yoshioka, N., & Dowdy, S. F.
Affiliations
University of California San Diego (US)
Corresponding author
Dowdy, Steven F.
Venue
PLOS ONE
Published
2017-07-27
Volume
12
Issue
7
Pages
e0182018
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2740231295
Cited by
36
References
26
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 4
FWCI
1.45
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Keck Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
induced pluripotent stem cells, reprogramming factors, aging, Oct4, KLF4, SOX2, GLIS1, c-Myc, LIN28A, transfection efficiency, cardiomyopathy
MeSH terms
Kruppel-Like Factor 4, Adult, Aged, Animals, Clone Cells, Female, Fibroblasts, Humans, Infant, Newborn, Male, Middle Aged, RNA, Transfection, Cell Culture Techniques, Mice, Young Adult, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.